NDWClass II
Assay, Porphyrin, Spectrophotometry, Lithium
21 CFR 862.3560 / Clinical Toxicology
NDW is the FDA product code for Assay, Porphyrin, Spectrophotometry, Lithium, a class II device type, regulated under 21 CFR 862.3560. As of , FDA records hold 7 510(k) clearances under this code, the most recent dated , and 7 recalls.
Classification record
- Product code
- NDW
- Device name
- Assay, Porphyrin, Spectrophotometry, Lithium
- Regulation
- 21 CFR 862.3560
- Device class
- Class II
- Review panel
- Clinical Toxicology
- Submission type
- 510(k)
- Implant
- No
- Life sustaining or supporting
- No
- GMP exempt
- No
- Third party review eligible
- Yes
- Ingested clearances
- 7
- Ingested recalls
- 7
Clearances, product code NDW
By decision yearShow the numbers
| Year | Clearances |
|---|---|
| 2001 | 1 |
| 2005 | 1 |
| 2007 | 2 |
| 2008 | 1 |
| 2011 | 1 |
| 2025 | 1 |
Applicants with the most clearances
Product code NDW| Applicant | Clearances |
|---|---|
| Medrad, Inc. | 1 |
| Diazyme Laboratories, Inc. | 1 |
| Roche Diagnostics GmbH | 1 |
| Sentinel CH SpA | 1 |
| Siemens Healthcare Diagnostics Inc. | 1 |
| Thermo Electron Oy | 1 |
| Trace America, Inc. | 1 |
Companies listing this code with FDA
Companies whose registered establishments list this codeFIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
